SAGE Therapeutics (SAGE) Misses Q3 EPS by 5c
SAGE Therapeutics (NASDAQ: SAGE) reported Q3 EPS of ($1.15), $0.05 worse than the analyst estimate of ($1.10).
For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.
SAGE Therapeutics (NASDAQ: SAGE) reported Q3 EPS of ($1.15), $0.05 worse than the analyst estimate of ($1.10).
For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.